Case-Control Studies
Research News and Information

Saturday, November 21, 2009

Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma.

29 Nov 2009 Our previous study has suggested that the cell cycle-related kinase (CCRK) is a putative candidate oncogene in glioblastoma tumorigenesis. The potential oncogenic role of CCRK and its clinical/prognostic significance, however, in ovarian carcinoma ... Read more...

IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.

29 Nov 2009 The mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) encodes a protein that plays a critical role in tumor suppression, in part by modulating bioavailability of a potent mitogen, insulin-like growth factor-2 (IGF2). We tested ... Read more...

Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer.

29 Nov 2009 Although preliminary evidence suggests that germline variation in genes involved in steroid hormone metabolism may alter breast cancer prognosis, this has not been systematically evaluated. We examined associations between germline polymorphisms in ... Read more...

Latest indexed articles for 'Case-Control Studies'

These are the very latest articles for this heading:

• Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma. 29 Nov 2009
• IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas. 29 Nov 2009
• Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer. 29 Nov 2009
• Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection. 29 Nov 2009
• Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome. 29 Nov 2009
• Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination. 29 Nov 2009
• High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission. 13 Nov 2009
• Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. 13 Nov 2009
• Characteristics of menstruation and pregnancy and the risk of lung cancer in women. 13 Nov 2009
• The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms. 13 Nov 2009
• Two distinct subtypes of right temporal variant frontotemporal dementia. Nov 2009
• Pickled vegetables and the risk of oesophageal cancer: a meta-analysis. Nov 2009
• Triggering of nocturnal arrhythmias by sleep-disordered breathing events. Nov 2009
• Alpha1-adrenergic blockers and intraoperative floppy-iris syndrome. 30 Oct 2009
• Progression and prognosis of gastric stump cancer. 30 Oct 2009
• Prognostic effect of inadvertent curettage without treatment delay in osteosarcoma. 30 Oct 2009
• Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy. 30 Oct 2009
• Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms. 30 Oct 2009
• Altered corticostriatal functional connectivity in obsessive-compulsive disorder. 30 Oct 2009
• Altered effect of dopamine transporter 3'UTR VNTR genotype on prefrontal and striatal function in schizophrenia. 30 Oct 2009

See a longer list of these articles.

Technical information about 'Case-Control Studies'

Definition: Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.

Descriptor UI: D016022

Alternative terms: Case-Control Studies; Case-Control Study; Studies, Case-Control; Study, Case-Control; Case-Comparison Studies; Case Comparison Studies; Case-Comparison Study; Studies, Case-Comparison; Study, Case-Comparison; Case-Compeer Studies; Case Compeer Studies; Case-Compeer Study; Studies, Case-Compeer; Study, Case-Compeer; Case-Referrent Studies; Case Referrent Studies; Case-Referrent Study; Studies, Case-Referrent; Study, Case-Referrent; Case-Referent Studies; Case Referent Studies; Case-Referent Study; Studies, Case-Referent; Study, Case-Referent; Case-Base Studies; Case Base Studies; Case-Base Study; Studies, Case-Base; Study, Case-Base; Case Control Studies; Case Control Study; Studies, Case Control; Study, Case Control; Matched Case-Control Studies; Case-Control Studies, Matched; Case-Control Study, Matched; Matched Case Control Studies; Matched Case-Control Study; Studies, Matched Case-Control; Study, Matched Case-Control; Nested Case-Control Studies; Case-Control Studies, Nested; Case-Control Study, Nested; Nested Case Control Studies; Nested Case-Control Study; Studies, Nested Case-Control; Study, Nested Case-Control;

Tree Number: E05.318.760.500.500; N05.715.360.775.175.200; N06.850.520.450.500.500;

History Note: 90

Technical Notes: IM GEN only; coord NIM with specific disease (IM); no qualif; specify geog if pertinent